Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, February 07, 2014
Northwest Biotherapeutics, Inc. (NASDAQ: NWBO)
(“NW Bio”), a biotechnology company developing non-toxic DCVax® personalized immune
therapies for solid tumor cancers, announced today that Dr. Marnix Bosch, Chief Technical Officer of
NW Bio, will ...
read more
Bormioli Pharma, a manufacturer of pharmaceutical packaging and medical devices, announced a significant increase of 47% in its North American sales for 2023. This notable growth is a direct result of the company's rapidly evolving infrastructure and...
read more
Wednesday, March 12, 2025
CordenPharma announced the signing of a strategic partnership with Viking Therapeutics, Inc., a clinical-stage company focused on developing novel therapies for metabolic and endocrine disorders. Under this multi-year supply contract, CordenPharma ...
read more
CUNY (City University of New York) and Genestack Ltd are pleased to announce their collaboration aimed at streamlining data curation for the BioConductor program.
read more
Monday, November 14, 2022
BioNTech announced its Singapore affiliate BioNTech Pharmaceuticals Asia Pacific entered into an agreement with Novartis Singapore Pharmaceutical Manufacturing to acquire one of its GMP-certified manufacturing facilities. Supported by the Singapore ...
read more
PCI Pharma Services has released its first Environmental, Social & Governance (ESG) Report. A detailed overview of PCI's multifaceted sustainability journey, the report showcases the strides taken from the program's formal inception in 2021 through ...
read more
Thursday, October 24, 2019
Vertex announced an access agreement with NHS England for all currently licensed Vertex cystic fibrosis medicines and any future indications of these medicines.
read more
Tuesday, January 14, 2020
Catalent announced the launch of FlexDirect™, a new direct-to-patient service for clinical trials.
read more
Thursday, October 31, 2013
“The launch of the new brand logo is an outward sign of an important transformation that’s been ongoing for the past couple of years,” said John D. Bucksath, President and CEO. “The entire organization has worked very hard to get where we are today. ...
read more
Wednesday, December 09, 2015
America’s biopharmaceutical companies are currently developing 190 medicines to treat heart disease and stroke, according to a new report released from the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Association of Black ...
read more
TFF Pharmaceuticals, Inc. and Catalent announced their collaboration agreement focused on the generation, testing and manufacture of dry powder formulations for a range of biotherapeutics through the application of TFF Pharmaceuticals’ patented Thin ...
read more
Wednesday, January 03, 2024
Frontage Laboratories, Inc. has successfully completed the acquisition of the Bioanalytical and Drug Metabolism & Pharmacokinetics businesses of Accelera S.r.l (Accelera) through its wholly-owned subsidiary Frontage Europe S.r.l. Accelera, a Contract...
read more
Tuesday, December 08, 2020
Beijing Biocytogen, Biocytogen Boston Corp, announced they have reached an agreement with Xencor, Inc., for the licensing of Biocytogen's fully human antibody RenMab/RenLite Mouse platform.
read more
Friday, February 26, 2021
C2 PHARMA (C2P) has expanded its portfolio of APIs and botanical extracts throughout 2020 and will continue pursuing the expansion into 2021.
read more
WuXi AppTec announced it has acquired Pharmapace, a US-based clinical research services company with expertise of providing high quality biometrics services.
read more